Last 12 months
Inside the activity.
0 purchase rows · 1 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2025 Filed Mar 18, 2025 20:31 UTC |
Masoud MaherDirector · President and CEO
|
GrantEmployee Stock Option (right to buy) · Derivative | 347,500 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000905148-25-000961 · form4.xml · derivative · entry 1 Masoud Maher · CIK 0001874571 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 347,500 Underlying: Common Stock · 347,500 shares Expires 2035-03-13 F1 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest on March 14, 2026, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 14, 2025 Filed Mar 19, 2025 00:33 UTC |
Swirsky Douglas JCHIEF FINANCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 150,000 | $0.00 Strike: $3.29 | $0.00 |
DisclosureSEC source: 0000905148-25-000962 · form4.xml · derivative · entry 2 Swirsky Douglas J · CIK 0001375884 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2035-03-13 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest on March 14, 2026, and the remainder shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| March 14, 2025 Filed Mar 19, 2025 00:33 UTC |
Swirsky Douglas JCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 37,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-25-000962 · form4.xml · nonDerivative · entry 1 Swirsky Douglas J · CIK 0001375884 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 118,750 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on March 14, 2026, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:13 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-25-002263 · form4-01292025_090107.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 17,417 Underlying: Common Stock · 3,000 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:13 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 3,000 | $4.65 | $13,935.00 |
DisclosureSEC source: 0001415889-25-002263 · form4-01292025_090107.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.52 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 27, 2025 Filed Jan 29, 2025 21:13 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 3,000 | $2.93 | $8,796.00 |
DisclosureSEC source: 0001415889-25-002263 · form4-01292025_090107.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| January 13, 2025 Filed Jan 14, 2025 16:03 UTC |
Sandoval David I.GENERAL COUNSEL
|
SaleCommon Stock | 4,466 | $4.54 | $20,271.62 |
DisclosureSEC source: 0000905148-25-000092 · form4.xml · nonDerivative · entry 1 Sandoval David I. · CIK 0002012430 · GENERAL COUNSEL 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,447 F1 · kind: These shares were sold to cover tax withholding due upon vesting of previously granted restricted stock units. Such "sale to cover" was automatically effected to satisfy tax withholding obligations and does not represent a discretionary trade by the Reporting Person. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 21:15 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-030230 · form4-12302024_041201.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,417 Underlying: Common Stock · 3,000 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 21:15 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 3,000 | $4.01 | $12,021.00 |
DisclosureSEC source: 0001415889-24-030230 · form4-12302024_041201.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.995 to $4.06, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 26, 2024 Filed Dec 30, 2024 21:15 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 3,000 | $2.93 | $8,796.00 |
DisclosureSEC source: 0001415889-24-030230 · form4-12302024_041201.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 483 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · derivative · entry 10 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 23,417 Underlying: Common Stock · 483 shares Expires 2028-07-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,121 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · derivative · entry 9 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,121 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 891 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · derivative · entry 8 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 891 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 2,495 | $3.79 | $9,458.55 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · nonDerivative · entry 6 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.705 to $3.84, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 483 | $2.93 | $1,416.16 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · nonDerivative · entry 5 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 1,121 | $1.64 | $1,839.56 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · nonDerivative · entry 4 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 143,962 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| December 09, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 891 | $2.93 | $2,607.07 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · nonDerivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,841 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 505 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · derivative · entry 7 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 891 Underlying: Common Stock · 505 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 505 | $3.70 | $1,869.01 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.705, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 06, 2024 Filed Dec 10, 2024 21:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 505 | $2.93 | $1,477.63 |
DisclosureSEC source: 0001415889-24-028839 · form4-12102024_041201.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 142,455 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:25 UTC |
Erck Stanley CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 47,689 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001415889-24-026144 · form4-11052024_041101.xml · derivative · entry 3 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 47,689 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:25 UTC |
Erck Stanley CDirector
|
SaleCommon Stock | 47,689 | $3.72 | $177,403.08 |
DisclosureSEC source: 0001415889-24-026144 · form4-11052024_041101.xml · nonDerivative · entry 2 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,118 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.61 to $3.755, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 01, 2024 Filed Nov 5, 2024 21:25 UTC |
Erck Stanley CDirector
|
Exercise / conversionCommon Stock | 47,689 | $0.04 | $1,907.56 |
DisclosureSEC source: 0001415889-24-026144 · form4-11052024_041101.xml · nonDerivative · entry 1 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 316,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:15 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-025749 · form4-10302024_041006.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,396 Underlying: Common Stock · 3,000 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:15 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 3,000 | $3.72 | $11,166.00 |
DisclosureSEC source: 0001415889-24-025749 · form4-10302024_041006.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.70 to $3.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 28, 2024 Filed Oct 30, 2024 20:15 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 3,000 | $2.93 | $8,778.00 |
DisclosureSEC source: 0001415889-24-025749 · form4-10302024_041006.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:36 UTC |
Collins CynthiaDirector
|
GrantStock Option (right to buy) · Derivative | 97,698 | $0.00 Strike: $3.87 | $0.00 |
DisclosureSEC source: 0000905148-24-002726 · form4.xml · derivative · entry 2 Collins Cynthia · CIK 0001405692 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,698 Underlying: Common Stock · 97,698 shares Expires 2034-10-13 F2 · derivative.exercise_date: One-third of the shares underlying this option shall vest on October 14, 2025, and the remainder shall vest in twenty-four (24) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| October 14, 2024 Filed Oct 16, 2024 21:36 UTC |
Collins CynthiaDirector
|
GrantCommon Stock | 51,679 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-002726 · form4.xml · nonDerivative · entry 1 Collins Cynthia · CIK 0001405692 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,679 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. One hundred percent (100%) of the RSUs shall vest on October 14, 2025, subject to the Reporting Person's continued service to the Issuer through such vesting date. Read SEC document |
| October 02, 2024 Filed Oct 2, 2024 21:03 UTC |
Erck Stanley CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 21,607 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001415889-24-024454 · form4-10022024_091036.xml · derivative · entry 6 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,689 Underlying: Common Stock · 21,607 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 02, 2024 Filed Oct 2, 2024 21:03 UTC |
Erck Stanley CDirector
|
SaleCommon Stock | 21,607 | $3.71 | $80,161.97 |
DisclosureSEC source: 0001415889-24-024454 · form4-10022024_091036.xml · nonDerivative · entry 4 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,118 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.625 to $3.77, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 02, 2024 Filed Oct 2, 2024 21:03 UTC |
Erck Stanley CDirector
|
Exercise / conversionCommon Stock | 21,607 | $0.04 | $864.28 |
DisclosureSEC source: 0001415889-24-024454 · form4-10022024_091036.xml · nonDerivative · entry 3 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 290,725 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 21:03 UTC |
Erck Stanley CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 26,082 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001415889-24-024454 · form4-10022024_091036.xml · derivative · entry 5 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,296 Underlying: Common Stock · 26,082 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 21:03 UTC |
Erck Stanley CDirector
|
SaleCommon Stock | 26,082 | $3.78 | $98,589.96 |
DisclosureSEC source: 0001415889-24-024454 · form4-10022024_091036.xml · nonDerivative · entry 2 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,118 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.69 to $3.88, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| October 01, 2024 Filed Oct 2, 2024 21:03 UTC |
Erck Stanley CDirector
|
Exercise / conversionCommon Stock | 26,082 | $0.04 | $1,043.28 |
DisclosureSEC source: 0001415889-24-024454 · form4-10022024_091036.xml · nonDerivative · entry 1 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 295,200 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. Read SEC document |
| September 26, 2024 Filed Sep 30, 2024 20:15 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-024090 · form4-09302024_040901.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,396 Underlying: Common Stock · 3,000 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| September 26, 2024 Filed Sep 30, 2024 20:15 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 3,000 | $3.82 | $11,460.00 |
DisclosureSEC source: 0001415889-24-024090 · form4-09302024_040901.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.80 to $3.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 26, 2024 Filed Sep 30, 2024 20:15 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 3,000 | $2.93 | $8,778.00 |
DisclosureSEC source: 0001415889-24-024090 · form4-09302024_040901.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 16:34 UTC |
Soleymannezhad AliChief Commercial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 20,800 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000905148-24-002566 · form4.xml · derivative · entry 2 Soleymannezhad Ali · CIK 0002037336 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,800 Underlying: Common Stock · 20,800 shares Expires 2034-09-15 F2 · derivative.exercise_date: Twenty-five percent (25%) of the shares underlying this option shall vest on September 16, 2025, and the remainder shall vest in thirty-six (36) substantially equal monthly installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| September 16, 2024 Filed Sep 18, 2024 16:34 UTC |
Soleymannezhad AliChief Commercial Officer
|
GrantCommon Stock | 10,400 | $0.00 | $0.00 |
DisclosureSEC source: 0000905148-24-002566 · form4.xml · nonDerivative · entry 1 Soleymannezhad Ali · CIK 0002037336 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,025 F1 · shares: These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. Twenty-five percent (25%) of the RSUs shall vest on September 16, 2025, and the remainder shall vest in three (3) equal annual installments thereafter, subject to the Reporting Person's continued service to the Issuer through each vesting date. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 21:10 UTC |
Erck Stanley CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 29,767 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001415889-24-022941 · form4-09052024_090936.xml · derivative · entry 6 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 95,378 Underlying: Common Stock · 29,767 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 21:10 UTC |
Erck Stanley CDirector
|
SaleCommon Stock | 29,767 | $3.97 | $118,174.99 |
DisclosureSEC source: 0001415889-24-022941 · form4-09052024_090936.xml · nonDerivative · entry 4 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,118 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $3.90 to $4.07, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 04, 2024 Filed Sep 5, 2024 21:10 UTC |
Erck Stanley CDirector
|
Exercise / conversionCommon Stock | 29,767 | $0.04 | $1,190.68 |
DisclosureSEC source: 0001415889-24-022941 · form4-09052024_090936.xml · nonDerivative · entry 3 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 298,885 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:10 UTC |
Erck Stanley CDirector
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,922 | $0.00 Strike: $0.04 | $0.00 |
DisclosureSEC source: 0001415889-24-022941 · form4-09052024_090936.xml · derivative · entry 5 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 125,145 Underlying: Common Stock · 17,922 shares Expires 2024-11-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F4 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:10 UTC |
Erck Stanley CDirector
|
SaleCommon Stock | 17,922 | $4.10 | $73,480.20 |
DisclosureSEC source: 0001415889-24-022941 · form4-09052024_090936.xml · nonDerivative · entry 2 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 269,118 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.04 to $4.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 03, 2024 Filed Sep 5, 2024 21:10 UTC |
Erck Stanley CDirector
|
Exercise / conversionCommon Stock | 17,922 | $0.04 | $716.88 |
DisclosureSEC source: 0001415889-24-022941 · form4-09052024_090936.xml · nonDerivative · entry 1 Erck Stanley C · CIK 0001342826 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 287,040 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2024. The option that is the subject of the trading plan is scheduled to expire by its terms on November 11, 2024. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionStock Option (right to buy) · Derivative | 3,000 | $0.00 Strike: $2.93 | $0.00 |
DisclosureSEC source: 0001415889-24-022448 · form4-08282024_040806.xml · derivative · entry 3 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 7,396 Underlying: Common Stock · 3,000 shares Expires 2027-07-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F3 · derivative.exercise_date: This option is fully vested and exercisable. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:30 UTC |
Johnston John JosephDirector
|
SaleCommon Stock | 3,000 | $4.28 | $12,840.00 |
DisclosureSEC source: 0001415889-24-022448 · form4-08282024_040806.xml · nonDerivative · entry 2 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,950 F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. F2 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.23 to $4.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 26, 2024 Filed Aug 28, 2024 20:30 UTC |
Johnston John JosephDirector
|
Exercise / conversionCommon Stock | 3,000 | $2.93 | $8,778.00 |
DisclosureSEC source: 0001415889-24-022448 · form4-08282024_040806.xml · nonDerivative · entry 1 Johnston John Joseph · CIK 0001874850 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 144,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2023. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 18:57 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 17,857 | $0.00 Strike: $1.64 | $0.00 |
DisclosureSEC source: 0001415889-24-020785 · form4-08052024_100803.xml · derivative · entry 6 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1 Underlying: Common Stock · 17,857 shares Expires 2030-01-20 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F4 · derivative.exercise_date: The option has fully vested. Read SEC document |
| August 02, 2024 Filed Aug 5, 2024 18:57 UTC |
Ross Thomas M.EVP, GLOBAL SALES
|
SaleCommon Stock | 17,857 | $4.36 | $77,874.38 |
DisclosureSEC source: 0001415889-24-020785 · form4-08052024_100803.xml · nonDerivative · entry 4 Ross Thomas M. · CIK 0001874572 · EVP, GLOBAL SALES 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,000 F1 · kind: The sales and option exercises reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 19, 2024. F3 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.235 to $4.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.